Otsuka picks up PTSD drug with $700M Transcend buy
HealthcarePlatform
Otsuka→Transcend
Mar 27, 2026
Substance Abuse Treatment M&A Deals
5 dealsTrack substance abuse treatment acquisitions and investments within the healthcare sector.
Gilead Sciences to acquire Ouro Medicines, expanding autoimmune therapy portfolio - Proactive financial news
HealthcareOther
Gilead Sciences→Ouro Medicines
Mar 24, 2026
Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases
HealthcareOther
Gilead Sciences→Ouro Medicines
Mar 23, 2026
Chesterton addiction treatment center acquired by Alabama provider - Inside INdiana Business
HealthcareAlabama
Chesterton addiction treatment center
Feb 24, 2026
Sobi Announces Acquisition of Arthrosi Therapeutics to Bolster Development of Novel Gout Therapies - The Healthcare Technology Report.
HealthcareCaliforniaAdd-on
Sobi→Arthrosi Therapeutics
Jan 5, 2026